Sangamo Therapeutics
SGMO
SGMO
193 hedge funds and large institutions have $571M invested in Sangamo Therapeutics in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 59 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 59
16% less capital invested
Capital invested by funds: $679M → $571M (-$107M)
Holders
193
Holding in Top 10
–
Calls
$7.57M
Puts
$5.1M
Top Buyers
| 1 | +$8.28M | |
| 2 | +$6.91M | |
| 3 | +$3.85M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.57M |
| 5 |
BlackRock
New York
|
+$2.79M |
Top Sellers
| 1 | -$4.72M | |
| 2 | -$3.25M | |
| 3 | -$3.21M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$3.14M |
| 5 |
MIG
McGuire Investment Group
Wakefield,
Rhode Island
|
-$2.06M |